PainReform Ltd. (PRFX) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
PRFX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PRFX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | 82.6% | -10312.8% | -10223.3% |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export PRFX earnings history in CSV or JSON format
Free sign-in required to download data
PainReform Ltd. (PRFX) Earnings Overview
As of May 8, 2026, PainReform Ltd. (PRFX) reported trailing twelve-month net income of -$4M, reflecting +81.2% year-over-year growth. The company earned $-1.92 per diluted share over the past four quarters.
Looking at the long-term picture, PRFX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$828,000 in fiscal 2018.
PainReform Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PCRX ($9M net income, 1.0% margin), ACRS (-$65M net income, -829.6% margin), NKTR (-$164M net income, -297.1% margin), PRFX has comparable earnings metrics. Compare PRFX vs PCRX →
PRFX Earnings vs Peers
Earnings metrics vs comparable public companies
PRFX Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$15M | -56.1% | -$15M | $-32.16 | - | - |
| 2023 | -$9M | -6.3% | -$10M | $-171.33 | - | - |
| 2022 | -$9M | -21.3% | -$9M | $-197.92 | -10223.3% | -10312.8% |
| 2021 | -$7M | -78.8% | -$7M | $-177.23 | - | - |
| 2020 | -$4M | -122.7% | -$2M | $-83.05 | - | - |
| 2019 | -$2M | -119.8% | $-689,000 | $-62.11 | - | - |
| 2018 | $-828,000 | +60.4% | $-500,000 | $-48.32 | - | - |
| 2017 | -$2M | - | $-880,000 | $-36.25 | - | - |
See PRFX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRFX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRFX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRFX — Frequently Asked Questions
Quick answers to the most common questions about buying PRFX stock.
Is PRFX growing earnings?
PRFX EPS is $-1.92, with earnings growth accelerating to +81.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-4M.
What are PRFX's profit margins?
PainReform Ltd. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are PRFX's earnings?
PRFX earnings data spans 2017-2024. The accelerating earnings trend is +81.2% YoY. Historical data enables comparison across business cycles.